SE0302381D0 - New salts I - Google Patents
New salts IInfo
- Publication number
- SE0302381D0 SE0302381D0 SE0302381A SE0302381A SE0302381D0 SE 0302381 D0 SE0302381 D0 SE 0302381D0 SE 0302381 A SE0302381 A SE 0302381A SE 0302381 A SE0302381 A SE 0302381A SE 0302381 D0 SE0302381 D0 SE 0302381D0
- Authority
- SE
- Sweden
- Prior art keywords
- compounds
- relates
- present
- salts
- new salts
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 3
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical class N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- SUBDBMMJDZJVOS-DEOSSOPVSA-N esomeprazole Chemical class C([S@](=O)C1=NC2=CC=C(C=C2N1)OC)C1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-DEOSSOPVSA-N 0.000 abstract 2
- 229960004770 esomeprazole Drugs 0.000 abstract 2
- 229960000381 omeprazole Drugs 0.000 abstract 2
- QHKGZGABGGEUOC-UHFFFAOYSA-N adamantane;azane Chemical compound N.C1C(C2)CC3CC1CC2C3 QHKGZGABGGEUOC-UHFFFAOYSA-N 0.000 abstract 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 abstract 1
- 229960003805 amantadine Drugs 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
- C04B35/632—Organic additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
- C07C211/38—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ceramic Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Inorganic Chemistry (AREA)
- Structural Engineering (AREA)
- Materials Engineering (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0302381A SE0302381D0 (sv) | 2003-09-04 | 2003-09-04 | New salts I |
| PCT/SE2004/001258 WO2005023796A1 (en) | 2003-09-04 | 2004-09-01 | New salts of omeprazole and esomeprazole i |
| CA002549465A CA2549465A1 (en) | 2003-09-04 | 2004-09-01 | New salts of omeprazole and esomeprazole i |
| EP04775364A EP1664019A1 (en) | 2003-09-04 | 2004-09-01 | New salts of omerazole and esomerazole i |
| JP2006525304A JP2007504222A (ja) | 2003-09-04 | 2004-09-01 | オメプラゾール及びエソメプラゾールｉの新規な塩 |
| US10/569,819 US7326724B2 (en) | 2003-09-04 | 2004-09-01 | Salts of omeprazole and esomeprazole I |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0302381A SE0302381D0 (sv) | 2003-09-04 | 2003-09-04 | New salts I |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE0302381D0 true SE0302381D0 (sv) | 2003-09-04 |
Family
ID=28787270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0302381A SE0302381D0 (sv) | 2003-09-04 | 2003-09-04 | New salts I |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7326724B2 (enExample) |
| EP (1) | EP1664019A1 (enExample) |
| JP (1) | JP2007504222A (enExample) |
| CA (1) | CA2549465A1 (enExample) |
| SE (1) | SE0302381D0 (enExample) |
| WO (1) | WO2005023796A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0302382D0 (sv) | 2003-09-04 | 2003-09-04 | Astrazeneca Ab | New salts II |
| US7576219B2 (en) | 2005-10-26 | 2009-08-18 | Hanmi Pharm. Co., Ltd | Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same |
| EP1801110A1 (en) | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Esomeprazole arginine salt |
| US20090197919A1 (en) * | 2006-06-07 | 2009-08-06 | Rolf Bergman | Novel Method for Preparation of Ammonium Salts of Esomeprazole |
| EA200900985A1 (ru) | 2007-01-31 | 2009-12-30 | Крка, Товарна Здравил, Д. Д., Ново Место | Способ получения оптически чистого омепразола |
| EP2499125B1 (en) | 2009-11-12 | 2016-01-27 | Hetero Research Foundation | Process for the resolution of omeprazole |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| US4316905A (en) * | 1980-07-01 | 1982-02-23 | E. R. Squibb & Sons, Inc. | Mercaptoacyl derivatives of various 4-substituted prolines |
| SE8301182D0 (sv) * | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
| SE9301830D0 (sv) | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
| SE504459C2 (sv) | 1994-07-15 | 1997-02-17 | Astra Ab | Förfarande för framställning av substituerade sulfoxider |
| SE508669C2 (sv) | 1996-04-26 | 1998-10-26 | Astra Ab | Nytt förfarande |
| SE510650C2 (sv) | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
| ES2286408T3 (es) | 2002-03-05 | 2007-12-01 | Astrazeneca Ab | Sales de alquilamonio de omeprazol e esomeprazol. |
| SE0302382D0 (sv) | 2003-09-04 | 2003-09-04 | Astrazeneca Ab | New salts II |
-
2003
- 2003-09-04 SE SE0302381A patent/SE0302381D0/xx unknown
-
2004
- 2004-09-01 JP JP2006525304A patent/JP2007504222A/ja active Pending
- 2004-09-01 EP EP04775364A patent/EP1664019A1/en not_active Ceased
- 2004-09-01 US US10/569,819 patent/US7326724B2/en not_active Expired - Fee Related
- 2004-09-01 CA CA002549465A patent/CA2549465A1/en not_active Abandoned
- 2004-09-01 WO PCT/SE2004/001258 patent/WO2005023796A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005023796A8 (en) | 2006-04-06 |
| JP2007504222A (ja) | 2007-03-01 |
| CA2549465A1 (en) | 2005-03-17 |
| US7326724B2 (en) | 2008-02-05 |
| WO2005023796A1 (en) | 2005-03-17 |
| US20070004778A1 (en) | 2007-01-04 |
| EP1664019A1 (en) | 2006-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9900274D0 (sv) | New compound | |
| YU60999A (sh) | Novi oblik s-omeprazola | |
| CY1108024T1 (el) | Αλατα αλκυλαμμωνιου ομεπραζολης και εσομεπραζολης | |
| EE04279B1 (et) | Omeprasooli kristalne vorm | |
| UA32524C2 (uk) | Спосіб одержання омепразолу | |
| ATE504570T1 (de) | Tartratsalz aus isofagomin und verwendungsverfahren dafür | |
| NO20092464L (no) | Faste former av rasemisk ilaprazol | |
| KR101062806B1 (ko) | 광학적으로 순수한 활성 화합물의 제조 방법 | |
| NO20052474L (no) | Amort form av esomeprazolsalter | |
| SE0104295D0 (sv) | New process | |
| SE0302382D0 (sv) | New salts II | |
| HRP20030853A2 (en) | Crystalline form of omeprazole | |
| WO2005023796A8 (en) | New salts of omeprazole and esomeprazole i | |
| PT1575941E (pt) | Processo para a preparação de (s)-pantoprazole | |
| EA200501594A1 (ru) | Замещенные производные азабициклогексана в качестве антагонистов мускаринового рецептора | |
| MXPA05009183A (es) | Polimorfos de s-omeprazol. | |
| DE602007010926D1 (de) | Neues verfahren zur herstellung von ammoniumsalzen von esomeprazol | |
| MY118724A (en) | New crystalline form of omeprazole | |
| YU32301A (sh) | Novi kristalni oblik omeprazola | |
| KR20070031945A (ko) | 피리딘-2-일메틸설피닐-1ｈ-벤즈이미다졸 화합물의 제조방법 |